10 Tanimoto Tanimoto Y Y Yokozeki Yokozeki M M Hiura Hiura K K Matsumoto Matsumoto K K Nakanishi Nakanishi H H Moriyama Moriyama K K A soluble form of fibroblast growth factor receptor 2 (FGFR: S252W mutation acts as an efficient inhibitor for the enhance osteoblastic differentiation caused by FGFR2 activation in Apert syndrome A soluble form of fibroblast growth factor receptor 2 (FGFR: S252W mutation acts as an efficient inhibitor for the enhance osteoblastic differentiation caused by FGFR2 activation in Apert syndrome J Biol Chem. J Biol Chem. 2004 2004 13 13 770 770 785 785. This evidence concerns the gene FGFR2 and Apert syndrome.